Using Global Onshoring Trends to Identify Industry Gaps in Life Sciences
As life science companies encounter ever-evolving challenges to get their new products to global markets – lagging COVID-19 related supply chain setbacks, increased regulation, and worldwide inflation uncertainty, to name a few – they are increasingly turning to outsourcing and onshoring as solutions.
Cambrex, in partnership with Citeline, recently surveyed 100 industry leaders to see how they are using the capabilities of contract development and manufacturing organizations (CDMOs) and onshoring to advance their development processes.
Download our whitepaper to:
- Access survey analysis
- Understand how life sciences leaders are leveraging the power of CDMO partnerships
- See industry utilization of dual sourcing approaches
- Look at trends over time in preferences for CDMO locality
- Identify the regions where future project sourcing is likely to be prevalent